August 13, 2021 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on DrugPa…
August 13, 2021 Comments Off on New patent for DUSA drug LEVULAN Posted in: Patent Added Annual Drug Patent Expirations for LEVULAN Levulan is a drug marketed by Dusa and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for DUSA drug LEVULAN appeared first on DrugPatentWatch – M…
